California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$84.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ARCT Arcturus Therapeutics Holdings Inc.	$487M	$528,000 0.0% of portfolio	22,780	Q3 2024 Reduced 3.54%
PLRX Pliant Therapeutics, Inc.	$626M	$518,000 0.0% of portfolio	46,257	Q3 2024 Added 2.97%
ABUS Arbutus Biopharma Corp	$544M	$516,000 0.0% of portfolio	134,270	Q3 2024 Added 1,228.49%
ETNB 89bio, Inc.	$410M	$505,000 0.0% of portfolio	68,351	Q3 2024 Reduced 3.15%
IBRX Immunity Bio, Inc.	$1.95B	$487,000 0.0% of portfolio	131,324	Q3 2024 Reduced 0.67%
SANA Sana Biotechnology, Inc.	$493M	$482,000 0.0% of portfolio	115,931	Q3 2024 Reduced 10.32%
LQDA Liquidia Corp	$646M	$442,000 0.0% of portfolio	44,203	Q3 2024 Reduced 9.52%
ERAS Erasca, Inc.	$343M	$437,000 0.0% of portfolio	160,436	Q3 2024 Added 1,863.24%
HUMA Humacyte, Inc.	$499M	$430,000 0.0% of portfolio	79,140	Q3 2024 Added 1,142.58%
RGNX Regenxbio Inc.	$482M	$418,000 0.0% of portfolio	39,884	Q3 2024 Reduced 2.99%
ALT Altimmune, Inc.	$415M	$411,000 0.0% of portfolio	66,964	Q3 2024 Reduced 3.52%
SVRA Savara Inc	$364M	$400,000 0.0% of portfolio	94,567	Q3 2024 Added 23.89%
YMAB Y M Abs Therapeutics, Inc.	$507M	$387,000 0.0% of portfolio	29,481	Q3 2024 Reduced 3.18%
OLMA Olema Pharmaceuticals, Inc.	$408M	$383,000 0.0% of portfolio	32,136	Q3 2024 Reduced 3.48%
EYPT Eye Point Pharmaceuticals, Inc.	$357M	$374,000 0.0% of portfolio	46,817	Q3 2024 Added 0.96%
REPL Replimune Group, Inc.	$562M	$371,000 0.0% of portfolio	33,932	Q3 2024 Reduced 20.28%
ALLO Allogene Therapeutics, Inc.	$354M	$358,000 0.0% of portfolio	127,869	Q3 2024 Reduced 8.65%
URGN Uro Gen Pharma Ltd.	$270M	$354,000 0.0% of portfolio	27,920	Q3 2024 Added 1,021.74%
SRRK Scholar Rock Holding Corp	$1.42B	$346,000 0.0% of portfolio	43,254	Q3 2024 Reduced 1.26%
STOK Stoke Therapeutics, Inc.	$549M	$339,000 0.0% of portfolio	27,600	Q3 2024 Reduced 16.58%
NUVB Nuvation Bio Inc.	$623M	$329,000 0.0% of portfolio	143,070	Q3 2024 Added 5.67%
ATXS Astria Therapeutics, Inc.	$160M	$326,000 0.0% of portfolio	29,626	Q3 2024 Added 807.94%
ORIC Oric Pharmaceuticals, Inc.	$349M	$317,000 0.0% of portfolio	30,942	Q3 2024 Reduced 11.86%
TNGX Tango Therapeutics, Inc.	$345M	$313,000 0.0% of portfolio	40,767	Q3 2024 Reduced 3.27%
SAGE Sage Therapeutics, Inc.	$319M	$312,000 0.0% of portfolio	43,352	Q3 2024 Reduced 3.18%
TYRA Tyra Biosciences, Inc.	$686M	$304,000 0.0% of portfolio	12,936	Q3 2024 Added 778.8%
ALEC Alector, Inc.	$405M	$302,000 0.0% of portfolio	64,740	Q3 2024 Reduced 2.93%
FATE Fate Therapeutics Inc	$202M	$286,000 0.0% of portfolio	81,778	Q3 2024 Reduced 8.78%
FDMT 4 D Molecular Therapeutics, Inc.	$260M	$283,000 0.0% of portfolio	26,243	Q3 2024 Reduced 9.81%
TBPH Theravance Biopharma, Inc.	$639M	$278,000 0.0% of portfolio	34,503	Q3 2024 Reduced 2.94%
VERV Verve Therapeutics, Inc.	$322M	$273,000 0.0% of portfolio	56,454	Q3 2024 Reduced 2.99%
TRDA Entrada Therapeutics, Inc.	$597M	$261,000 0.0% of portfolio	16,352	Q3 2024 Reduced 3.4%
EDIT Editas Medicine, Inc.	$190M	$252,000 0.0% of portfolio	74,106	Q3 2024 Reduced 3.51%
RVNC Revance Therapeutics, Inc.	$212M	$241,000 0.0% of portfolio	94,163	Q3 2024 Reduced 3.25%
PHVS Pharvaris N.V.	$694M	$239,000 0.0% of portfolio	12,950	Q3 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$200M	$235,000 0.0% of portfolio	150,300	Q3 2024 Added 1,706.71%
ITOS I Teos Therapeutics, Inc.	$301M	$202,000 0.0% of portfolio	19,859	Q3 2024 Reduced 13.77%
LYEL Lyell Immunopharma, Inc.	$273M	$169,000 0.0% of portfolio	122,493	Q3 2024 Reduced 3.46%
SMMT Summit Therapeutics Inc.	$3.82B	$139,000 0.0% of portfolio	6,384	Q3 2024 Added 0.65%
APLT Applied Therapeutics Inc.	$446M	$59,000 0.0% of portfolio	6,966	Q2 2024 New
ADPT Adaptive Biotechnologies Corp	$797M	$42,000 0.0% of portfolio	8,392	Q2 2024 Reduced 91.81%
ANNX Annexon, Inc.	$301M	$41,000 0.0% of portfolio	6,994	Q3 2024 Added 14.58%
TERN Terns Pharmaceuticals, Inc.	$250M	$34,000 0.0% of portfolio	4,171	Q2 2024 Reduced 87.01%
KALV Kal Vista Pharmaceuticals, Inc.	$241M	$33,000 0.0% of portfolio	2,853	Q3 2024 Added 3.41%
CRMD Cor Medix Inc.	$453M	$32,000 0.0% of portfolio	3,980	Q2 2024 Reduced 27.98%
AVXL Anavex Life Sciences Corp.	$626M	$31,000 0.0% of portfolio	5,493	Q3 2024 Added 4.13%
CELC Celcuity Inc.	$211M	$29,000 0.0% of portfolio	1,977	Q3 2024 Added 16.77%
AURA Aura Biosciences, Inc.	$292M	$29,000 0.0% of portfolio	3,361	Q2 2024 Reduced 6.3%
XERS Xeris Biopharma Holdings, Inc.	$415M	$28,000 0.0% of portfolio	10,161	Q2 2024 Reduced 24.06%
CAPR Capricor Therapeutics, Inc.	$447M	$27,000 0.0% of portfolio	1,839	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.